Research suggests that certain weight-loss drugs, including GLP-1 medications, may also have a potential benefit in reducing cancer risk. Some studies indicate that these drugs could lower the risk of breast cancer, possibly by as much as 30%. The exact relationship between these medications and cancer risk is still being explored, with experts and researchers seeking to understand the underlying mechanisms.